Back to search

Article

Targeting STAT3 abrogates Tim-3 upregulation of adaptive resistance to PD-1 blockade on regulatory T cells of melanoma

2020-10-01

Abstract excerpt

<h4>Background: </h4> Programmed cell death-1 (PD-1) blockade immunotherapies have demonstrated excellent clinical benefits in multiple cancers, but < 20% of melanoma patients respond to these treatments. Thus, it is crucial to understand for getting awareness of the dynamic changes vibrant transformations in the tumor microenvironment (TME) after PD-1 blockade, in exploring novel intervention targets as a potenti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
443ba0db-db86-51cd-bd38-77b8829e227a
DOI
10.21203/rs.3.rs-83300/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting STAT3 abrogates Tim-3 upregulation of adaptive resistance to PD-1 blockade on regulatory T cells of melanomaDOI 10.21203/rs.3.rs-83300/v1
Select a neighboring publication to make it the new centre.